Q1 2025 Holdings
Filed 2025-05-15 | 56 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $141.4M | 4,398,281 | 13.4% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $133.0M | 737,675 | 12.6% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $77.8M | 9,533,669 | 7.4% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $57.0M | 4,788,945 | 5.4% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $48.1M | 4,051,927 | 4.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $47.8M | 4,898,527 | 4.5% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $39.8M | 1,014,139 | 3.8% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $38.0M | 939,277 | 3.6% |
| Immunome Inc(IMNM) | COM | 45257U108 | $36.1M | 5,361,187 | 3.4% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $34.3M | 4,794,780 | 3.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $31.4M | 1,610,329 | 3.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $29.8M | 4,485,981 | 2.8% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $26.9M | 983,413 | 2.5% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $22.1M | 15,666,731 | 2.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $20.9M | 867,454 | 2.0% |
| Absci Corporation(ABSI) | COM | 00091E109 | $20.7M | 8,253,316 | 2.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $19.5M | 193,283 | 1.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $19.3M | 3,216,026 | 1.8% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $15.3M | 1,308,063 | 1.4% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $13.7M | 1,886,444 | 1.3% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $13.7M | 335,366 | 1.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $12.2M | 6,300,644 | 1.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $10.7M | 590,175 | 1.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $10.2M | 12,872,946 | 1.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $8.8M | 534,600 | 0.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.4M | 490,394 | 0.8% |
| Ceribell Inc(CBLL) | COM | 15678C102 | $8.4M | 435,239 | 0.8% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $7.9M | 6,475,317 | 0.7% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $7.5M | 2,019,171 | 0.7% |
| Insulet Corp(PODD) | COM | 45784P101 | $7.1M | 27,109 | 0.7% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $6.7M | 73,071 | 0.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $6.2M | 2,214,947 | 0.6% |
| Penumbra Inc(PEN) | COM | 70975L107 | $6.1M | 22,843 | 0.6% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $6.0M | 56,844 | 0.6% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $5.6M | 552,506 | 0.5% |
| Verve Therapeutics Inc | COM | 92539P101 | $5.5M | 1,207,164 | 0.5% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $5.3M | 3,031,009 | 0.5% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $5.3M | 5,539,724 | 0.5% |
| Masimo Corp(MASI) | COM | 574795100 | $4.3M | 26,062 | 0.4% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $4.1M | 2,074,350 | 0.4% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $4.0M | 386,963 | 0.4% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $3.4M | 2,952,131 | 0.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.3M | 82,098 | 0.3% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $3.2M | 997,235 | 0.3% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $2.8M | 2,053,559 | 0.3% |
| Lava Therapeutics NV | SHS | N51517105 | $2.6M | 2,074,372 | 0.2% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $2.6M | 441,701 | 0.2% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $2.5M | 451,099 | 0.2% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $2.3M | 3,640,834 | 0.2% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $1.9M | 1,884,389 | 0.2% |